(Q53088995)

English

p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

p53 pathway activation by telomere attrition in X-DC primary fibroblasts occurs in the absence of ribosome biogenesis failure and as a consequence of DNA damage. (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

author name string

J Carrillo

1

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

A González

2

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

C Manguán-García

3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

L Pintado-Berninches

4

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

R Perona

5

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

publication date

25 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

Clinical and Translational Oncology

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

16

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

6

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

529-538

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

https://scigraph.springernature.com/pub.10.1007/s12094-013-1112-3

0 references

Clinical utility gene card for: dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Dyskerin ablation in mouse liver inhibits rRNA processing and cell division

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

A zebrafish model of dyskeratosis congenita reveals hematopoietic stem cell formation failure resulting from ribosomal protein-mediated p53 stabilization.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Zebrafish models for dyskeratosis congenita reveal critical roles of p53 activation contributing to hematopoietic defects through RNA processing

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

S6-haploinsufficiency activates the p53 tumor suppressor

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

High resolution melting analysis for the identification of novel mutations in DKC1 and TERT genes in patients with dyskeratosis congenita.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

A DNA damage checkpoint response in telomere-initiated senescence

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Defending the end zone: studying the players involved in protecting chromosome ends

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Functional links between telomeres and proteins of the DNA-damage response

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Eroded human telomeres are more prone to remain uncapped and to trigger a G2 checkpoint response.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

A dyskerin motif reactivates telomerase activity in X-linked dyskeratosis congenita and in telomerase-deficient human cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

The p53/p21(WAF/CIP) pathway mediates oxidative stress and senescence in dyskeratosis congenita cells with telomerase insufficiency.

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Dyskeratosis congenita

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1112-3

21 January 2018

Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of cytotoxic effect of mitomycin-C by superoxide dismutase in Fanconi's anemia and dyskeratosis congenita fibroblasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dyskeratosis congenita

1 reference

https://pubmed.ncbi.nlm.nih.gov/24065372

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12094-013-1112-3

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 May 2018

http://europepmc.org/abstract/MED/24065372

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53088995&oldid=1419809221"